Prostate Cancer

With the popularity of mail-away DNA tests and ancestry reports, people are learning more about what makes them who they are. Learning about your family history can be exciting, but this trend also has people curious about the health risks they may have inherited through family genetics.

You ask the internet a lot of questions, and Roswell Park has some answers. James Mohler, MD, Professor of Oncology, and Chair of the NCCN Prostate Cancer Guideline Committee, and Eric Kauffman, MD, Assistant Professor of Oncology, sat down to answer some of the internet's most-searched-for questions related to prostate cancer.
Participating in screening and early detection events is key to catching cancer early and we’re here to help you and those you love be proactive about their health.
Recognizing signs and symptoms of illness is always a good idea, but when it comes to cancer, and especially prostate cancer, symptoms are often vague, difficult to discern from normal, or don’t appear at all until the cancer advances.
How can prostate cancer treatment affect your ability to get an erection — and can the problem be corrected?

Every April, Roswell Park Comprehensive Cancer Center works to raise awareness about cancer among minority populations by recognizing National Minority Cancer Awareness Week, celebrated this year April 8-14, 2019.

It was 2005, and 47-year-old Rick Crowley had a lump growing in his neck. The first biopsy indicated that it was benign, but his doctors in Olean, New York, were not convinced. A good thing, too: The second biopsy found cancer.

All families have their traditions. In ours, we tend to have big families, with numerous siblings – and a lot of cancer. My father was diagnosed with cancer when he was 44 years old. They found it in his lungs, did a biopsy and took part of his lung out.

The fact that you live in a particular country or community should not impact your ability to get good care for cancer.

About 70 percent of men receive their diagnosis when the disease is in its early stages. In most of those cases, the cancer tends to grow slowly and will never cause symptoms or lead to death.
Dr. Gurkamal Chatta and his colleagues are conducting a phase I clinical trial of an immunotherapy for men with metastatic prostate cancer that has progressed in spite of standard treatment. “We are targeting an area of need where there are really no other effective therapies.”

Hormone therapy causes side effects that can have a serious impact on the patient's quality of life, but men are often reluctant to talk about them or ask for help. A new education group aims to get the word out: "There is hope."